Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 12.21M | 6.79M | 6.11M | 6.84M | 4.22M | 1.92M |
Gross Profit | -3.42M | 6.79M | -5.09M | -1.98M | -2.86M | -4.42M |
EBITDA | -3.89M | -41.97M | -22.27M | -5.53M | -9.00M | -6.61M |
Net Income | -30.63M | -42.56M | -22.73M | -17.36M | -9.46M | -6.93M |
Balance Sheet | ||||||
Total Assets | 122.80M | 98.96M | 141.56M | 152.20M | 54.12M | 24.04M |
Cash, Cash Equivalents and Short-Term Investments | 94.59M | 81.96M | 117.00M | 140.74M | 46.53M | 19.90M |
Total Debt | 1.03M | 910.20K | 1.18M | 772.14K | 982.50K | 38.40K |
Total Liabilities | 8.12M | 8.01M | 9.62M | 3.51M | 3.57M | 1.97M |
Stockholders Equity | 114.68M | 90.95M | 131.94M | 148.69M | 50.55M | 22.07M |
Cash Flow | ||||||
Free Cash Flow | 4.73M | 2.86M | 5.85M | -2.43M | 287.28K | -4.96M |
Operating Cash Flow | 4.95M | 3.02M | 6.14M | -2.34M | 412.64K | -4.78M |
Investing Cash Flow | 7.75M | -2.61M | 7.56M | -114.40M | -40.06M | 9.79M |
Financing Cash Flow | 2.47M | 403.06K | 2.34M | 114.55M | 38.20M | -199.34K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | 1.04B | 14.07 | 79.32% | 11.35% | 25.67% | 744.90% | |
64 Neutral | 642.32M | 35.84 | 7.85% | ― | 1.06% | -30.96% | |
62 Neutral | 880.15M | -93.93 | 0.00% | ― | 0.40% | -280.65% | |
55 Neutral | 615.73M | -15.11 | -42.56% | ― | 333.23% | 10.83% | |
51 Neutral | 13.35M | -0.24 | 0.00% | ― | 0.00% | -1034.67% | |
48 Neutral | $1.33B | ― | -37.20% | ― | 5.81% | -86.09% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
Global Laser Enrichment (GLE), the exclusive licensee of Silex’s uranium enrichment technology, has successfully completed large-scale enrichment demonstration testing in North Carolina, marking a significant milestone towards commercial deployment. This advancement positions GLE as the only company operating large-scale, third-generation laser-based enrichment technology, with plans to further develop a domestic manufacturing base in the US. The project’s success could significantly impact the nuclear fuel production industry, with potential contributions to both current and future nuclear reactor fleets.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited has announced its 2025 Annual General Meeting (AGM) scheduled for October 17, 2025, which will be conducted as a hybrid event allowing both in-person and online participation. The AGM will cover several key business items, including the adoption of the 2025 Remuneration Report, re-election of a director, and approval of incentive plans for the CEO, which could impact the company’s governance and strategic direction.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited announced the quotation of 4,978,649 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of September 5, 2025. This development is part of previously announced transactions and could potentially impact the company’s market presence and liquidity, offering stakeholders an opportunity to engage with the company’s growth trajectory.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited has announced the issuance of 150,600 fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX). This move is part of the company’s strategy to enhance its market presence and potentially increase its capital base, which could have implications for its operations and stakeholders.
The most recent analyst rating on (AU:SLX) stock is a Buy with a A$6.64 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited announced the successful completion of its Share Purchase Plan (SPP), raising approximately $19.4 million, surpassing the initial target of $15 million. The funds will support the commercialization of the SILEX uranium enrichment technology in the US and other isotope enrichment opportunities, enhancing the company’s market positioning and operational capabilities.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited announced a change in the director’s interest, with Michael Goldsworthy acquiring 45,000 fully paid ordinary shares through the vesting of Performance Rights under the company’s Employee Incentive Plan. This change reflects the company’s commitment to aligning executive interests with performance-based goals, potentially impacting the company’s operational focus and stakeholder confidence.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited announced the cessation of certain securities, specifically 239,203 performance rights and 50,000 options, due to their expiry without exercise or conversion. This cessation reflects a routine adjustment in the company’s issued capital, which may impact stakeholders’ perceptions of the company’s financial strategy and market positioning.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited announced the quotation of 318,997 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective August 29, 2025. This move is part of the company’s strategy to expand its capital base and enhance its market presence, potentially impacting its financial operations and offering new opportunities for stakeholders.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.
Silex Systems Limited’s 2025 Annual Report highlights the ongoing development and commercialization efforts of its SILEX technology, particularly in uranium enrichment in collaboration with Global Laser Enrichment LLC. The company is also advancing projects in quantum silicon production and medical isotope separation, though these initiatives face various risks and uncertainties. The report underscores the speculative nature of these technologies’ commercial futures, influenced by market conditions, regulatory changes, and geopolitical factors.
The most recent analyst rating on (AU:SLX) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Silex Systems Limited stock, see the AU:SLX Stock Forecast page.